Related Experiment Video
Updated: Jan 16, 2026

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder
Published on: June 18, 2018
Methamphetamine abstainer's "cool" and "hot" prepotent response inhibition
Shu-Ho Chen1, Ming-Hong Hsieh2,3, Chieh-Liang Huang4
1Department of Psychology, Chung-Shan Medical University, Taichung, Taiwan.
For methamphetamine (MA) abstainers, improved inhibitory control is linked to longer abstinence duration, not addiction severity. This suggests interventions targeting cognitive control may aid recovery and reduce relapse risk.
Area of Science:
- Neuroscience
- Psychology
- Addiction Research
Background:
- Methamphetamine (MA) abuse is a significant public health concern in Taiwan.
- Impaired inhibitory control is a key factor contributing to relapse in MA addiction.
- Research on inhibitory control deficits in MA abstainers, particularly across different contexts, is limited.
Purpose of the Study:
- To investigate prepotent response inhibition in MA abstainers compared to healthy controls.
- To examine inhibitory control in both neutral ("cool") and drug-related ("hot") contexts.
- To explore the relationship between inhibitory control and factors like abstinence duration and addiction severity.
Main Methods:
- A modified antisaccade task was employed with "cool" (neutral images) and "hot" (MA-related images) conditions.
- Twenty-four male MA abstainers and 24 healthy controls participated.
- Prepotent response inhibition was assessed, and correlations with clinical variables were analyzed.
Main Results:
- No significant differences in prepotent response inhibition were found between MA abstainers and healthy controls across conditions.
- In MA abstainers, enhanced prepotent response inhibition positively correlated with longer duration of abstinence.
- Inhibitory control did not correlate with addiction severity, treatment duration, or past use history in abstainers.
Conclusions:
- Prepotent response inhibition in MA abstainers is more strongly associated with the duration of abstinence than with long-term addiction severity or treatment history.
- Interventions focused on enhancing inhibitory control may be beneficial for reducing relapse risk and improving recovery outcomes in MA abstainers.
More Related Videos
08:05A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
Published on: January 5, 2018
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Related Concept Videos
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Desensitization and Tachyphylaxis
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists